Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease

NCT00629603

Conditions: Blood-Borne Infections, Chronic Liver Disease, Communicable Diseases, +12 more
Locations: Kaohsiung Medical University Chung-Ho Hospital Kaohsiung City, Kaohsiung, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Kaohsiung, Taiwan

View Trial Details

Completed

TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.

NCT00741169

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations: Not specified

View Trial Details

Completed

Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

NCT00295607

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Prague, Czechia

Besançon, France

Lyon, France

Nice, France

View all 17 locations

View Trial Details

Completed

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

NCT01134718

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

TMC435-TiDP16-C112 - Interaction Trial With Antidepressants

NCT01090700

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies

NCT00872196

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Site Reference ID/Investigator# 18222 Los Angeles, California, United States

View Trial Details

Completed

TMC649128HPC1001 - First In-human Trial to Examine Safety, Tolerability, and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses of TMC649128 in Healthy Volunteers

NCT01288677

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment

NCT00680342

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

University of North Carolina Chapel Hill, North Carolina, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)

NCT01378104

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Soonchunghyang University Hospital Bucheon-si, South Korea

Hallym University Chunchun Medical center Chunchun, South Korea

Keimyung University hospital Daegu, South Korea

Kyungpook National University Hospital Daegu, South Korea

View all 14 locations

View Trial Details

Completed

TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients

NCT01202825

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Antwerp, Belgium

View Trial Details

Flaviviridae Infections

Flaviviridae Infections trial results

Related conditions